Last reviewed · How we verify
NCT06706843
The Effect of Transtheoretical Model-based Motivational Interview on Self-efficacy and Illness Compliance
NA trial testing Transtheoretical Model Based Motivational Interviewing in Hemodialysis Units, Hospital in 60 participants. Completed in 30 March 2023.
30 September 2022
Quick facts
| Lead sponsor | HÜSEYİN ÇAPUK |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 30 June 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 March 2023 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Transtheoretical Model Based Motivational Interviewing
- routine clinical care
Conditions studied
- Hemodialysis Units, Hospital — all drugs for Hemodialysis Units, Hospital →
Sponsor
HÜSEYİN ÇAPUK
Who can join
Adults 18 to 75, any sex, with Hemodialysis Units, Hospital. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim: This study was planned to determine the effect of transtheoretical model-based motivational interviewing on patients\' self-efficacy and disease adherence in patients receiving haemodialysis treatment. Study design and methods: This study was conducted between June 2022 and April 2023 according to the experimental research model with pre-test and post-test control group. The research was completed with a total of 60 hemodialysis patients, 30 in the experimental group and 30 in the control group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Impact of Transtheoretical Model-Based Motivational Interviewing on Self-Efficacy and Adherence to Treatment in Hemodialysis Patients.
Çapuk H, Aylaz R. · · 2025 · PMID 40492930 · DOI 10.1111/jep.70152
Verify or expand the search:
- PubMed search for NCT06706843
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06706843 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HÜSEYİN ÇAPUK
- Last refreshed: 27 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06706843.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing